CVE-2026-21970 json
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).
published 9mo ago modified 4mo ago also EUVD-2026-3542
- cvss
- 6.5
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.3%
- EPSS 0.3% chance of exploitation in 30 days, percentile 21%
- public exploits
- 0
- none known
Summary
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
Is CVE-2026-21970 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.
Check with FencerCISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- partial
- Assessed
- 9mo ago
Exploit prediction
0.29% chance of exploitation in the next 30 days, higher than 21% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 6.5 | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N |
Affected products
- Oracle Corporation Oracle Life Sciences Central Designer
References
-
oracle.com
/security-alerts/cpujan2026.html
vendor-advisory
Sources
- CVE List CVE-2026-21970
- NVD CVE-2026-21970
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.